All trials
NCT06523296NARECRUITING

Presence of Anti-RACH Antibodies and Neurocognitive Disorder in Myasthenic or Alzheimers's Patients.

Eligibility check — Phoenix members

Phoenix members see for THIS trial:

  • APOE genotype match
  • Cognitive status fits inclusion
  • Specific exclusions flagged
  • Distance to nearest site
Check my eligibility — become a member
Sites
1 location
Start
2024-04-17

Interventions tested

  • PROCEDUREAdults with Alzheimer's disease
  • PROCEDUREAdults with Myasthenia
  • OTHERHealhty controls
View full record on ClinicalTrials.gov

We use cookies to enhance your experience.